Reunion Neuroscience is committed to innovating therapeutic solutions to treat mental health conditions through the development of novel psychedelic compounds. NASDAQ:REUN
Location: Canada, Ontario, Toronto
Employees: 1-10
Investors 3
| Date | Name | Website |
| 06.08.2023 | MPM Capita... | mpmcapital... |
| - | Femtech Ca... | femtech.ca... |
| - | MPM BioImp... | mpmbioimpa... |
Mentions in press and media 3
| Date | Title | Description |
| 13.11.2025 | Clarivate Companies to Watch Report Spotlights Seven Women's Health Startups Shaping the Future of Care | Report highlights emerging biotech innovators advancing new therapies, equity and investment across reproductive, chronic and mental health LONDON, Nov. 13, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of trans... |
| 02.05.2024 | Reunion Neuroscience Inc. Announces $103 Million Series A Financing Co-Led by MPM BioImpact and Novo Holdings | - |
| - | Reunion Neuroscience | “Reunion Neuroscience is a clinical stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions. ” |